Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly subcutaneous ZT-1 implant vs oral donepezil in moderate Alzheimer's disease
2006-005161-18Phase 2Completed
- Sponsor
- Debiopharm
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mimopezil in Alzheimer's disease (AD) (2 arms), sponsored by Debiopharm. Primary endpoint: Efficacy endpoints (cognitive, behavioral, and overall outcomes). Started Feb 2008; status: completed.
02
Drugs
mimopezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2006-005161-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005161-18.